MCRB News
Archived Headlines
- Seres Therapeutics prices upsized IPO at $18, above the range 06/26/15
- Week ahead: As many as 17 IPOs could price during the week of June 22 06/22/15
- Microbiome biotech Seres Therapeutics sets terms for $100 million IPO 06/16/15
- Seres of fortunate events: Seres Therapeutics files for a $100 million IPO to fight infections 05/27/15
Renaissance Capital's 2015 US IPO Annual Review
Coming off of two banner years, the 2015 IPO market was a disappointment with 169 IPOs raising only $30 billion, a six-year low. There is no single explanation for the decline in 2015 activity; rather, it was driven by a number of factors, including...read more
June 2015 was the most active month for IPOs since the Dotcom Bubble
June 2015 saw 35 initial public offerings, more than any month since August 2000, when 66 companies went public. Since then, there have now been just nine months with over 30 IPOs, including six in the past two years. The 35 June IPOs raised $5.9 billion, more ...read more
US IPO Market Takes Off Again in the Second Quarter: Renaissance Capital's 2Q 2015 Review
Click here to view the full report. IPO activity more than doubled during the second quarter compared to the slow first quarter, which hit a 2-year low. The 70 IPOs raised almost $13 billion, with each month this quarter having the year-to-date most IPOs,...read more
US IPO Weekly Recap: Year's hottest deal pops 186% in year's most active week with 13 IPOs
Things just got Seres in the IPO market. Thirteen companies went public this past week, more than any week since October 2014. Seres Therapeutics skyrocketed 186% on its debut - the highest first-day pop since January 2014. The thirteen IPOs raised $1.9...read more